Akebia Therapeutics and Par Pharma settle Auryxia suit

07-08-2019

Saman Javed

Akebia Therapeutics and Par Pharma settle Auryxia suit

Pavel Kapysh / Shutterstock.com

A subsidiary of Akebia Therapeutics has entered into a settlement agreement with Endo-owned Par Pharmaceutical.


Par Pharmaceutical, Akebia Therapeutics, settlement agreement, patent infringement, Panian & BF Biotech, Auryxia, dialysis

LSIPR